参考文献/References:
[1] Bowman AW,Kantor B,Gerber TC.Coronary computed tomographic angiography:current role in the diagnosis and management of coronary artery disease[J].Pol Arch Med Wewn,2009,119(6):381-390.
[2] Steigner ML,Mitsouras D,Whitmore AG,et al.Iodinated contrast opacification gradients in normal coronary arteries imaged with prospectively ECG-gated single heart beat 320-detector row computed tomography[J].Circ Cardiovasc Imaging,2010,3(2):179-186.
[3] Chow BJW,Kass M,Gagn O,et al.Can differences in corrected coronary opacification measured with computed tomography predict resting coronary artery flow?[J].J Am Coll Cardiol,2011,57(11):1280-1288.
[4] Koo HJ,Yang DH,Kim YH,et al.CT-based myocardial ischemia evaluation:quantitative angiography,transluminal attenuation gradient,myocardial perfusion,and CT-derived fractional flow reserve[J].Int J Cardiovasc Imaging,2016,32(suppl 1):1-19.
[5] Park EA,Lee W,Park SJ,et al.Influence of coronary artery diameter on intracoronary transluminal attenuation gradient during CT angiography[J].JACC Cardiovasc Imaging,2016,9(9):1074-1083.
[6] Suwannasom P,Nieman K,de Araújo Gon?alves P,et al.Functional evaluation of coronary disease by CT angiography[J].JACC Cardiovasc Imaging,2015,8(11):1322-1335.
[7] Cury RC,Abbara S,Achenbach S,et al.CAD-RADSTM:coronary artery disease?–?reporting and data system:an?expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT),the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology[J].J Am Coll Radiol,2016,13(12 Pt A):1458-1466.e9.
[8] Weigold WG,Abbara S,Achenbach S,et al.Standardized medical terminology for cardiac computed tomography:a report of the Society of Cardiovascular Computed Tomography [J].J Cardiovasc Comput Tomogr,2011,5(3):136-144.
[9] Wong DTL,Ko BS,Cameron JD,et al.Transluminal attenuation gradient in coronary computed tomography angiography is a novel noninvasive approach to the identification of functionally significant coronary artery stenosis:a comparison with fractional flow reserve [J].J Am Coll Cardiol,2013,61(12):1271-1279.
[10] Doris MK,Otaki Y,Arnson Y,et al.Non-invasive fractional flow reserve in vessels without severe obstructive stenosis is associated with coronary plaque burden[J].J Cardiovasc Comput Tomogr,2018,12(5):379-384.
[11] Stuijfzand WJ,Danad I,Raijmakers PG,et al.Additional value of transluminal attenuation gradient in CT angiography to predict hemodynamic significance of coronary artery stenosis[J].JACC Cardiovasc Imaging,2014,7(4):374-386.
[12] Choi JH,Min JK,Labounty TM,et al.Intracoronary transluminal attenuation gradient in coronary CT angiography for determining coronary artery stenosis[J].JACC Cardiovasc Imaging,2011,4(11):1149-1157.
[13] Gao Y,Lu B,Hou ZH,et al.Coronary in-stent restenosis:assessment with corrected coronary opacification difference across coronary stents measured with CT angiography[J].Radiology,2015,275(2):403-412.
[14] Choi JH,Kim EK,Kim SM,et al.Noninvasive discrimination of coronary chronic total occlusion and subtotal occlusion by coronary computed tomography angiography[J].JACC Cardiovasc Interv,2015,8(9):1143-1153.
[15] Li M.Disease:reverse attenuation gradient sign at CT indicates distal retrograde flow—a useful sign for differentiating chronic total occlusion from subtotal occlusion[J].Radiology,2013,266(3):766-772.
[16] 周思维,王鹏贺,左权,等.冠状动脉侧支循环研究进展[J].心血管病学进展,2018,39(4):521-524.
[17] Stuijifzand WJ,Danad I,Raijmakers PG,et al.Additional value of transluminal attenuation gradient in CT angiography to predict hemodynamic significance of coronary[J].JACC Cardiovasc Imaging,2014,7(4):374-386.
[18] Zheng M,Wei M,Wen D,et al.Transluminal attenuation gradient in coronary computed tomography angiography for determining stenosis severity of calcified coronary artery:a primary study with dual-source CT[J].Eur Radiol,2015,25(5):1219-1228.
[19] Peng K,Xu N,Zhang L,et al.Transluminal attenuation gradient and corrected models in coronary CT angiography for determining stenosis severity:a primary study using dual-source CT[J].Clin Radiol,2017,72(6):508-516.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(8):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(8):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(8):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(8):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(8):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(8):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[7]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(8):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[8]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(8):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[9]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(8):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[10]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(8):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]